Vijay H Shah Selected Research

Liver Diseases (Liver Disease)

1/2022	Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo.
1/2022	Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.
1/2022	Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population.
1/2022	Omics and AI advance biomarker discovery for liver disease.
1/2022	Development of the AI-Cirrhosis-ECG Score: An Electrocardiogram-Based Deep Learning Model in Cirrhosis.
11/2021	Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group.
11/2021	Transcriptomic Analysis Reveals the MicroRNAs Responsible for Liver Regeneration Associated With Mortality in Alcohol-Associated Hepatitis.
11/2021	Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study.
1/2021	Sex Differences in Alcohol Consumption and Alcohol-Associated Liver Disease.
1/2021	Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vijay H Shah Research Topics

Disease

48	Fibrosis (Cirrhosis) 04/2022 - 02/2006
33	Liver Diseases (Liver Disease) 01/2022 - 07/2010
23	Alcoholic Hepatitis 01/2021 - 06/2008
19	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 07/2010
16	Inflammation (Inflammations) 10/2022 - 07/2014
16	Portal Hypertension 01/2022 - 12/2005
13	Neoplasms (Cancer) 01/2022 - 10/2008
13	End Stage Liver Disease 01/2022 - 10/2008
11	Hepatitis 01/2022 - 12/2010
10	Non-alcoholic Fatty Liver Disease 10/2021 - 10/2006
7	Neoplasm Metastasis (Metastasis) 10/2019 - 10/2008
6	Alcoholism (Alcohol Abuse) 01/2022 - 01/2018
5	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2021 - 10/2006
4	Bacterial Infections (Bacterial Infection) 12/2021 - 09/2015
4	Infections 01/2019 - 12/2010
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 06/2009
4	Hemorrhage 01/2019 - 09/2006
3	Ascites 01/2022 - 11/2019
3	Obesity 01/2021 - 08/2013
3	Liver Failure 01/2021 - 04/2012
3	Acute-On-Chronic Liver Failure 09/2020 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 10/2015
2	Fatty Liver 10/2021 - 01/2020
2	Insulin Resistance 01/2020 - 01/2017
2	Cicatrix (Scar) 10/2019 - 05/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 06/2016
2	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 01/2018 - 08/2013
2	Hepatic Encephalopathy 10/2015 - 09/2006
1	Cholangitis 01/2022
1	Hepatitis A (Hepatitis, Infectious) 11/2021

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2006
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2006
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 10/2015
7	Interleukin-22 (IL-22)IBA 10/2021 - 09/2015
6	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022 - 01/2018
6	LigandsIBA 01/2021 - 06/2009
6	CytokinesIBA 01/2021 - 11/2008
5	ChemokinesIBA 10/2022 - 09/2020
5	Transcription Factors (Transcription Factor)IBA 04/2022 - 01/2013
5	EnzymesIBA 01/2022 - 01/2017
5	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 08/2011
5	Messenger RNA (mRNA)IBA 01/2021 - 10/2011
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2010 - 12/2005
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
4	SteroidsIBA 11/2021 - 04/2014
4	CollagenIBA 10/2021 - 06/2008
4	Ethanol (Ethyl Alcohol)IBA 10/2021 - 06/2016
3	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 02/2018
3	MicroRNAs (MicroRNA)IBA 11/2021 - 10/2011
3	Hydroxyproline (4 Hydroxyproline)IBA 04/2021 - 01/2017
3	LipidsIBA 01/2021 - 04/2016
3	Neuropilin-1IBA 05/2019 - 07/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 04/2012
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 10/2014
3	Pentoxifylline (Trental)FDA LinkGeneric 02/2016 - 06/2008
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2015 - 07/2010
2	Histones (Histone)IBA 04/2022 - 01/2021
2	Lysine (L-Lysine)FDA Link 04/2022 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2019
2	SodiumIBA 01/2022 - 01/2011
2	Alanine Transaminase (SGPT)IBA 01/2022 - 10/2006
2	FructoseIBA 10/2021 - 03/2017
2	Transferrin (beta 2 Transferrin)IBA 01/2021 - 01/2020
2	ChromatinIBA 01/2021 - 01/2021
2	Conditioned Culture MediaIBA 01/2021 - 01/2018
2	Phospholipases (Phospholipase)IBA 01/2021 - 01/2018
2	BilirubinIBA 01/2021 - 07/2017
2	nasIBA 02/2020 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 03/2017
2	IronIBA 01/2020 - 01/2020
2	AlbuminsIBA 01/2020 - 05/2014
2	Bortezomib (Velcade)FDA Link 11/2019 - 02/2006
2	PeriostinIBA 10/2019 - 01/2017
2	Therapeutic UsesIBA 05/2019 - 03/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2017 - 01/2016
2	Biological ProductsIBA 01/2017 - 07/2014
2	Dynamin IIIBA 01/2017 - 04/2014
2	Platelet-Derived Growth FactorIBA 10/2014 - 08/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014 - 07/2010
2	Fibronectins (Fibronectin)IBA 08/2012 - 04/2012
2	Toll-Like Receptor 4IBA 04/2012 - 08/2010
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2012 - 10/2006
2	Peptide Hydrolases (Proteases)FDA Link 08/2010 - 10/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2009 - 12/2008
2	Nitric Oxide Synthase (NO Synthase)IBA 10/2008 - 06/2008
1	Interleukin-8 (Interleukin 8)IBA 10/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	AcyltransferasesIBA 01/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2021

Therapy/Procedure

28	Therapeutics 01/2022 - 06/2008
15	Liver Transplantation 01/2022 - 09/2006
14	Ligation 01/2022 - 09/2006
4	Transplantation 01/2022 - 08/2013
3	Drug Therapy (Chemotherapy) 01/2022 - 08/2011
3	Bariatric Surgery 01/2021 - 11/2019
3	Intraperitoneal Injections 01/2020 - 03/2017
3	Subcutaneous Injections 01/2019 - 12/2008
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022